Budget Amount *help |
¥4,000,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥600,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,400,000 (Direct Cost: ¥1,400,000)
|
Research Abstract |
The first step of the pathogenesis of preeclampsia is thought to be the failure of fetus extravillous trophoblasts (EVT) invasion into maternal desidua. It is suggested to be resulted in shallow placentaion, followed by intrauterine growth retardation. However, the molecular mechanisms remain unclear. In this study, we found that shingoshine-1-phosphate (S1P) and lysophosphatidic acid (LPA), which are main lysophospholipids known as a chemical mediator of cell proliferation and motility, would be involved in the invasion of EVT. These would be targets for the new therapy of preeclampsia.
|